Here, we integrated IL13RA2 into a construct encoding for PDGFB and used the RCAS/Tva system to develop a novel immunocompetent GEMM that both recapitulates diffuse midline gliomas and expresses the human glioma-associated antigen IL13RA2. The gene discussed is PDGFB; the disease is central nervous system cancer.